Edwards Lifesciences Corp
N/A
USD
N/A
N/A
...
Chart
Financials
Description
EW Company Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
EW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view EW Smart Score
Score Breakdown
EW Company Description
Show More
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of EW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on EW's company Twitter account
WallStreetBets
Number of mentions of EW in WallStreetBets Daily Discussion
EW News
Recent insights relating to EW
CNBC Recommendations
Recent picks made for EW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in EW
Corporate Flights
Flights by private jets registered to EW
Our Analysis